ACL 2.26% $2.16 australian clinical labs limited

A good outcome from ACL holders IMO. Based on recent price and...

  1. 5 Posts.
    lightbulb Created with Sketch. 2
    A good outcome from ACL holders IMO. Based on recent price and performance the 0.75 share offer would’ve been a steal for HLS holders.

    I note ACL still appear very interested in a merger, and it reads like they are already planning ahead with the next steps regarding ACC (Federal Court). It almost reads like this was just a step in a planned longer process (with a renewed lower offer)

    It’ll be interesting to see what the market thinks of the news - whether it’s a positive or a negative.
    Last edited by HGB76: 15/12/23
 
watchlist Created with Sketch. Add ACL (ASX) to my watchlist
(20min delay)
Last
$2.16
Change
-0.050(2.26%)
Mkt cap ! $435.9M
Open High Low Value Volume
$2.21 $2.21 $2.16 $1.750M 802.6K

Buyers (Bids)

No. Vol. Price($)
9 11681 $2.16
 

Sellers (Offers)

Price($) Vol. No.
$2.17 19214 1
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
$2.16
  Change
-0.050 ( 1.87 %)
Open High Low Volume
$2.20 $2.21 $2.16 125221
Last updated 15.59pm 28/05/2024 ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.